These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 24829597)
21. Pyridostigmine but not 3,4-diaminopyridine exacerbates ACh receptor loss and myasthenia induced in mice by muscle-specific kinase autoantibody. Morsch M; Reddel SW; Ghazanfari N; Toyka KV; Phillips WD J Physiol; 2013 May; 591(10):2747-62. PubMed ID: 23440963 [TBL] [Abstract][Full Text] [Related]
22. Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis. Punga AR; Sawada M; Stålberg EV Muscle Nerve; 2008 Mar; 37(3):300-7. PubMed ID: 18069667 [TBL] [Abstract][Full Text] [Related]
23. Childhood-onset anti-MuSK antibody positive myasthenia gravis demonstrates a distinct clinical course. Takahashi Y; Sugiyama M; Ueda Y; Itoh T; Yagyu K; Shiraishi H; Ukeba-Terashita Y; Nakanishi M; Nagashima T; Imai T; Motomura M; Saitoh S Brain Dev; 2012 Oct; 34(9):784-6. PubMed ID: 22277190 [TBL] [Abstract][Full Text] [Related]
24. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509 [TBL] [Abstract][Full Text] [Related]
25. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody]. Konishi T Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139 [TBL] [Abstract][Full Text] [Related]
26. [Correlation between clinical manifestation, prognosis and antibody in anti-muscle-specific tyrosine kinase antibody positive myasthenia gravis]. Tan Y; Zhu L; Huang YY; Shi JY; Li J; Li K; Guan YZ; Cui LY Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2433-2437. PubMed ID: 34399555 [No Abstract] [Full Text] [Related]
27. Acetylcholinesterase inhibitors in MG: to be or not to be? Punga AR; Stålberg E Muscle Nerve; 2009 Jun; 39(6):724-8. PubMed ID: 19260048 [TBL] [Abstract][Full Text] [Related]
28. MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK. Küçükerden M; Huda R; Tüzün E; Yılmaz A; Skriapa L; Trakas N; Strait RT; Finkelman FD; Kabadayı S; Zisimopoulou P; Tzartos S; Christadoss P J Neuroimmunol; 2016 Jun; 295-296():84-92. PubMed ID: 27235354 [TBL] [Abstract][Full Text] [Related]
29. The mouse passive-transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure. Ghazanfari N; Trajanovska S; Morsch M; Liang SX; Reddel SW; Phillips WD Ann N Y Acad Sci; 2018 Jan; 1412(1):54-61. PubMed ID: 29125188 [TBL] [Abstract][Full Text] [Related]
38. Comorbid Human Immunodeficiency Virus (HIV) and Muscle-Specific Kinase (MuSK) Myasthenia Gravis: A Case Report and Literature Review. Sherpa M; Metai RK; Kumar V; Hirachan T; Ahmed KU; Atkinson SJ Am J Case Rep; 2017 Apr; 18():427-430. PubMed ID: 28424453 [TBL] [Abstract][Full Text] [Related]
39. Electrophysiological profile of the patients with MuSK positive myasthenia gravis. Nikolic A; Basta I; Stojanovic VR; Stevic Z; Lavrnic D Neurol Res; 2014 Nov; 36(11):945-9. PubMed ID: 24825477 [TBL] [Abstract][Full Text] [Related]